Chairs
- Otto Metzger (Boston, MA, United States of America)
Next generation tyrosine kinase inhibitors (ID 197)
Lecture Time
14:00 - 14:20
Speakers
- Ana Mafalda Antunes De Melo e Oliveira (Barcelona, Spain)
Authors
- Ana Mafalda Antunes De Melo e Oliveira (Barcelona, Spain)
From SERMs to SERDs: Advances and challenges in the development of novel agents (focus on biomarkers) (ID 198)
Lecture Time
14:20 - 14:40
Speakers
- Otto Metzger (Boston, MA, United States of America)
Authors
- Otto Metzger (Boston, MA, United States of America)
Luminal HER2 positive vs luminal HER2 negative: Different drivers of endocrine resistance and the role of CDK4/6 inhibitors (ID 199)
Lecture Time
14:40 - 15:00
Speakers
- Luca Malorni (Prato, Italy)
Authors
- Luca Malorni (Prato, Italy)
Digital interactions in the management of targeted treatment (ID 200)
Lecture Time
15:00 - 15:20
Speakers
- Ines V. Vaz Luis (Villejuif, France)
Authors
- Ines V. Vaz Luis (Villejuif, France)
Q&A and discussion (ID 201)
Lecture Time
15:20 - 15:30
Speakers
- To be Announced (Barcelona, Spain)
Authors
- To be Announced (Barcelona, Spain)